Last updated on October 2017

Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis


Brief description of study

Primary Objective: Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH). Secondary Objectives: - Evaluate the safety profile of Hectorol® capsules versus Rocaltrol® (calcitriol) capsules. - Determine the pharmacokinetic profile of 1,25-dihydroxyvitamin D2 after administration of Hectorol®.

Detailed Study Description

The total study duration per patient will be approximately up to 28 weeks.

Clinical Study Identifier: NCT02859896

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

For site information, send an ...

Investigational Site Number 8400003
Orlando, FL United States
  Connect »

For site information, send an ...

Investigational Site Number 8400002
New Orleans, LA United States
  Connect »

For site information, send an ...

Investigational Site Number 8400014
Minneapolis, MN United States
  Connect »

For site information, send an ...

Investigational Site Number 8400010
Hackensack, NJ United States
  Connect »

For site information, send an ...

Investigational Site Number 8400007
New York, NY United States
  Connect »

For site information, send an ...

Investigational Site Number 8400004
Portland, OR United States
  Connect »

For site information, send an ...

Investigational Site Number 8400001
Marshfield, WI United States
  Connect »

For site information, send an ...

Investigational Site Number 0320004
San Miguel De Tucuman, Argentina
  Connect »

For site information, send an ...

Investigational Site Number 1520002
Santiago, Chile
  Connect »